Walleye Capital’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Walleye Capital’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-45,913	Closed	-$3.25K	–	5766
2024 Q3	$3.25K	Hold	45,913	–	–	﹤0.01%	5033
2024 Q2	$4.54K	Hold	45,913	–	–	﹤0.01%	5332
2024 Q1	$7.35K	Sell	45,913 -6,377	-12%	-$724	﹤0.01%	5105
2023 Q4	$4.22K	Buy	+52,290	New	+$7.05K	﹤0.01%	4674
2023 Q3	–	Sell	-17,273	Closed	-$3.46K	–	5424
2023 Q2	$3.46K	Hold	17,273	–	–	﹤0.01%	4084
2023 Q1	$2.42K	Buy	17,273 +3,200	+23%	+$455	﹤0.01%	3750
2022 Q4	$1.2K	Buy	14,073 +3,881	+38%	+$326	﹤0.01%	3040
2022 Q3	$2K	Hold	10,192	–	–	﹤0.01%	3069
2022 Q2	$3K	Hold	10,192	–	–	﹤0.01%	2206
2022 Q1	$6K	Hold	10,192	–	–	﹤0.01%	2178
2021 Q4	$12K	Sell	10,192 -288	-3%	-$293	﹤0.01%	2009
2021 Q3	$12	Buy	+10,480	New	+$13.1K	﹤0.01%	1535

Other funds holding NKGNW

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Walleye Capital's NKGNW Position: Q4 2024 in Review

Walleye Capital sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2024, closing a stake of 45,913 shares — an estimated $3.25K sold.

Walleye Capital first reported a position in NKGNW in Q3 2021 and held it in 12 quarters. The position peaked at $12K in Q4 2021. 26 funds tracked by Wall St. Rank hold NKGNW as of Q4 2024.

Walleye Capital reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2024 after selling out during the quarter.
Walleye Capital sold 45,913 NKGen Biotech, Inc. Warrants shares in Q4 2024, an estimated $3.25K.
Walleye Capital first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 12 quarters.
Walleye Capital's NKGen Biotech, Inc. Warrants position peaked at $12K in Q4 2021.
26 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.